End-joining, translocations and cancer

Nature Reviews Cancer

Volumn 13, Issue 7, 2013, Pages 443-454

  Bunting, Samuel F ^a   Nussenzweig, Andre ^b  

^a RUTGERS UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA;

CANCER CELL; CANCER GENETICS; CELL GROWTH; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPLICATION; DNA SEQUENCE; DNA STRAND; FUSION GENE; GENE SEQUENCE; GENOMIC INSTABILITY; HEMATOLOGIC MALIGNANCY; HOMOLOGOUS RECOMBINATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SOLID TUMOR; TELOMERE;

DNA END-JOINING REPAIR; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; ONCOGENE FUSION; TRANSLOCATION, GENETIC;

EID: 84881101184     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3537     Document Type: Review

References (131)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011).
2. Forment, J. V., Kaidi, A. & Jackson, S. P. Chromothripsis and cancer: Causes and consequences of chromosome shattering. Nature Rev. Cancer 12, 663-670 (2012).
3. Giardino, D. et al. De novo balanced chromosome rearrangements in prenatal diagnosis. Prenat Diagn. 29, 257-265 (2009).
4. Warburton, D. De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: Clinical significance and distribution of breakpoints. Am. J. Hum. Genet. 49, 995-1013 (1991).
5. Hakim, O. et al. DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature 484, 69-74 (2012).
6. Klein, I. A. et al. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147, 95-106 (2011).
7. Chiarle, R. et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 147, 107-119 (2011).
8. Kato, L. et al. Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes. Proc. Natl Acad. Sci. USA 109, 2479-2484 (2012).
9. Mitelman, F., Johansson, B. & Mertens, F. The impact of translocations and gene fusions on cancer causation. Nature Rev. Cancer 7, 233-245 (2007).
10. Rabbitts, T. H. Commonality but diversity in cancer gene fusions. Cell 137, 391-395 (2009).
11. Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648 (2005).
12. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
13. Stephens, P. J. et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462, 1005-1010 (2009).
14. Zhang, J. et al. The genetic basis of early Tcell precursor acute lymphoblastic leukaemia. Nature 481, 157-163 (2012).
15. Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214-220 (2011).
16. Cancer Genome Atlas Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519-525 (2012).
17. Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107-1120 (2012).
18. Krzywinski, M. et al. Circos: An information aesthetic for comparative genomics. Genome Res. 19, 1639-1645 (2009).
19. Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011).
20. Maher, C. A. & Wilson, R. K. Chromothripsis and human disease: Piecing together the shattering process. Cell 148, 29-32 (2012).
21. Berger, M. F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502-506 (2012).
22. Hastings, P. J., Lupski, J. R., Rosenberg, S. M. & Ira, G. Mechanisms of change in gene copy number. Nature Rev. Genet. 10, 551-564 (2009).
23. Llorente, B., Smith, C. E. & Symington, L. S. Break-induced replication: What is it and what is it for? Cell Cycle 7, 859-864 (2008).
24. Ruiz, J. F., Gomez-Gonzalez, B. & Aguilera, A. Chromosomal translocations caused by either pol32dependent or pol32independent triparental break-induced replication. Mol. Cell. Biol. 29, 5441-5454 (2009).
25. Smith, C. E., Llorente, B. & Symington, L. S. Template switching during break-induced replication. Nature 447, 102-105 (2007).
26. Shaw, C. J. & Lupski, J. R. Implications of human genome architecture for rearrangement-based disorders: The genomic basis of disease. Hum. Mol. Genet. 13, R57-R64 (2004).
27. Lieber, M. R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 79, 181-211 (2010).
28. Difilippantonio, M. J. et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404, 510-514 (2000).
29. Ferguson, D. O. et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc. Natl Acad. Sci. USA 97, 6630-6633 (2000).
30. Gao, Y. et al. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404, 897-900 (2000).
31. Saberi, A. et al. RAD18 and poly(ADP-ribose) polymerase independently suppress the access of nonhomologous end joining to double-strand breaks and facilitate homologous recombination-mediated repair. Mol. Cell. Biol. 27, 2562-2571 (2007).
32. Adamo, A. et al. Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia. Mol. Cell 39, 25-35 (2010).
33. Bunting, S. F. et al. BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol. Cell 46, 125-135 (2012).
34. Bunting, S. F. et al. 53BP1 inhibits homologous recombination in Brca1deficient cells by blocking resection of DNA breaks. Cell 141, 243-254 (2010).
35. Pace, P. et al. Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science 329, 219-223 (2010).
36. Patel, A. G., Sarkaria, J. N. & Kaufmann, S. H. Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc. Natl Acad. Sci. USA 108, 3406-3411 (2011).
37. Cancer Genome Atlas Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
38. Park, D. J. et al. Rare mutations in XRCC2 increase the risk of breast cancer. Am. J. Hum. Genet. 90, 734-739 (2012).
39. Stephens, P. J. et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400-404 (2012).
40. Thompson, E. R. et al. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet. 8, e1002894 (2012).
41. Roth, D. B., Porter, T. N. & Wilson, J. H. Mechanisms of nonhomologous recombination in mammalian cells. Mol. Cell. Biol. 5, 2599-2607 (1985).
42. Roth, D. B. & Wilson, J. H. Nonhomologous recombination in mammalian cells: Role for short sequence homologies in the joining reaction. Mol. Cell. Biol. 6, 4295-4304 (1986).
43. Boulton, S. J. & Jackson, S. P. Identification of a Saccharomyces cerevisiae Ku80 homologue: Roles in DNA double strand break rejoining and in telomeric maintenance. Nucleic Acids Res. 24, 4639-4648 (1996).
44. Boulton, S. J. & Jackson, S. P. Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways. EMBO J. 15, 5093-5103 (1996).
45. Kramer, K. M., Brock, J. A., Bloom, K., Moore, J. K. & Haber, J. E. Two different types of double-strand breaks in Saccharomyces cerevisiae are repaired by similar RAD52independent, nonhomologous recombination events. Mol. Cell. Biol. 14, 1293-1301 (1994).
46. Wang, H. et al. Biochemical evidence for Kuindependent backup pathways of NHEJ. Nucleic Acids Res. 31, 5377-5388 (2003).
47. Daley, J. M. & Wilson, T. E. Rejoining of DNA double-strand breaks as a function of overhang length. Mol. Cell. Biol. 25, 896-906 (2005).
48. Difilippantonio, M. J. et al. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 196, 469-480 (2002).
49. Zhu, C. et al. Unrepaired DNA breaks in p53deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109, 811-821 (2002).
50. Weinstock, D. M., Elliott, B. & Jasin, M. A model of oncogenic rearrangements: Differences between chromosomal translocation mechanisms and simple double-strand break repair. Blood 107, 777-780 (2006).
51. Boboila, C. et al. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J. Exp. Med. 207, 417-427 (2010).
52. Simsek, D. & Jasin, M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4ligase IV during chromosomal translocation formation. Nature Struct. Mol. Biol. 17, 410-416 (2010).
53. McVey, M. & Lee, S. E. MMEJ repair of double-strand breaks (director's cut): Deleted sequences and alternative endings. Trends Genet. 24, 529-538 (2008).
54. Tsai, A. G. et al. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell 135, 1130-1142 (2008).
55. Zhang, Y. & Jasin, M. An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway. Nature Struct. Mol. Biol. 18, 80-84 (2011).
56. Rass, E. et al. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nature Struct. Mol. Biol. 16, 819-824 (2009).
57. Xie, A., Kwok, A. & Scully, R. Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nature Struct. Mol. Biol. 16, 814-818 (2009).
58. Bothmer, A. et al. Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. J. Exp. Med. 210, 115-123 (2013).
59. Fattah, F. et al. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet. 6, e1000855 (2010).
60. Liang, L. et al. Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks. Nucleic Acids Res. 36, 3297-3310 (2008).
61. Simsek, D. et al. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet. 7, e1002080 (2011).
62. Boboila, C. et al. Robust chromosomal DNA repair via alternative end-joining in the absence of Xray repair cross-complementing protein 1 (XRCC1). Proc. Natl Acad. Sci. USA 109, 2473-2478 (2012).
63. Brunet, E. et al. Chromosomal translocations induced at specified loci in human stem cells. Proc. Natl Acad. Sci. USA 106, 10620-10625 (2009).
64. Robbiani, D. F. et al. AID is required for the chromosomal breaks in cmyc that lead to cmyc/IgH translocations. Cell 135, 1028-1038 (2008).
65. Chiang, C. et al. Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration. Nature Genet. 44, 390-397 (2012).
66. Huertas, P. DNA resection in eukaryotes: Deciding how to fix the break. Nature Struct. Mol. Biol. 17, 11-16 (2010).
67. Symington, L. S. & Gautier, J. Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 45, 247-271 (2011).
68. Frank-Vaillant, M. & Marcand, S. Transient stability of DNA ends allows nonhomologous end joining to precede homologous recombination. Mol. Cell 10, 1189-1199 (2002).
69. Kim, J. S. et al. Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. J. Cell Biol. 170, 341-347 (2005).
70. Mao, Z., Bozzella, M., Seluanov, A. & Gorbunova, V. Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst.) 7, 1765-1771 (2008).
71. Pierce, A. J., Hu, P., Han, M., Ellis, N. & Jasin, M. Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells. Genes Dev. 15, 3237-3242 (2001).
72. Difilippantonio, S. et al. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 456, 529-533 (2008).
73. Helmink, B. A. et al. H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1phase lymphocytes. Nature 469, 245-249 (2011).
74. Manis, J. P. et al. 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nature Immunol. 5, 481-487 (2004).
75. Ward, I. M. et al. 53BP1 is required for class switch recombination. J. Cell Biol. 165, 459-464 (2004).
76. Bothmer, A. et al. Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol. Cell 42, 319-329 (2011).
77. Bouwman, P. et al. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nature Struct. Mol. Biol. 17, 688-695 (2010).
78. Sfeir, A. & de Lange, T. Removal of shelterin reveals the telomere end-protection problem. Science 336, 593-597 (2012).
79. Buonomo, S. B., Wu, Y., Ferguson, D. & de Lange, T. Mammalian Rif1 contributes to replication stress survival and homology-directed repair. J. Cell Biol. 187, 385-398 (2009).
80. Chapman, J. R. et al. RIF1 is essential for 53BP1dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell 49, 858-871 (2013).
81. Di Virgilio, M. et al. Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching. Science 339, 711-715 (2013).
82. Escribano-Diaz, C. et al. A cell cycle-dependent regulatory circuit composed of 53BP1RIF1 and BRCA1CtIP controls DNA repair pathway choice. Mol. Cell 49, 872-883 (2013).
83. Zimmermann, M., Lottersberger, F., Buonomo, S. B., Sfeir, A. & de Lange, T. 53BP1 regulates DSB repair using Rif1 to control 5' end resection. Science 339, 700-704 (2013).
84. Neal, J. A. et al. Inhibition of homologous recombination by DNA-dependent protein kinase requires kinase activity, is titratable, and is modulated by autophosphorylation. Mol. Cell. Biol. 31, 1719-1733 (2011).
85. Shrivastav, M. et al. DNA-PKcs and ATM coregulate DNA double-strand break repair. DNA Repair (Amst.) 8, 920-929 (2009).
86. Zhang, S. et al. Congenital bone marrow failure in DNA-PKcs mutant mice associated with deficiencies in DNA repair. J. Cell Biol. 193, 295-305 (2011).
87. Richardson, C. & Jasin, M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405, 697-700 (2000).
88. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000).
89. Ramiro, A. R. et al. AID is required for cmyc/IgH chromosome translocations in vivo. Cell 118, 431-438 (2004).
90. Ramiro, A. R. et al. Role of genomic instability and p53 in AID-induced cmyc-Igh translocations. Nature 440, 105-109 (2006).
91. Misteli, T. Higher-order genome organization in human disease. Cold Spring Harb. Perspect. Biol. 2, a000794 (2010).
92. Osborne, C. S. et al. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol. 5, e192 (2007).
93. Roix, J. J., McQueen, P. G., Munson, P. J., Parada, L. A. & Misteli, T. Spatial proximity of translocation-prone gene loci in human lymphomas. Nature Genet. 34, 287-291 (2003).
94. Rocha, P. P. et al. Close proximity to Igh is a contributing factor to AID-mediated translocations. Mol. Cell 47, 873-885 (2012).
95. Zhang, Y. et al. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 148, 908-921 (2012).
96. Mahowald, G. K. et al. Aberrantly resolved RAG-mediated DNA breaks in Atm-deficient lymphocytes target chromosomal breakpoints in cis. Proc. Natl Acad. Sci. USA 106, 18339-18344 (2009).
97. Jackson, A. L. & Loeb, L. A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 477, 7-21 (2001).
98. Arlt, M. F., Durkin, S. G., Ragland, R. L. & Glover, T. W. Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst.) 5, 1126-1135 (2006).
99. Ozeri-Galai, E., Bester, A. C. & Kerem, B. The complex basis underlying common fragile site instability in cancer. Trends Genet. 28, 295-302 (2012).
100. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
101. Bester, A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435-446 (2011).
102. Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642 (2006).
103. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005).
104. Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355 (2008).
105. Barlow, J. H. et al. Identification of early replicating fragile sites that contribute to genome instability. Cell 152, 620-632 (2013).
106. Helmrich, A., Ballarino, M. & Tora, L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol. Cell 44, 966-977 (2011).
107. Cowell, I. G. et al. γH2AX foci form preferentially in euchromatin after ionising-radiation. PLoS ONE 2, e1057 (2007).
108. Kim, J. A., Kruhlak, M., Dotiwala, F., Nussenzweig, A. & Haber, J. E. Heterochromatin is refractory to γH2AX modification in yeast and mammals. J. Cell Biol. 178, 209-218 (2007).
109. Goodarzi, A. A. et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell 31, 167-177 (2008).
110. Ayoub, N., Jeyasekharan, A. D. & Venkitaraman, A. R. Mobilization and recruitment of HP1: A bimodal response to DNA breakage. Cell Cycle 8, 2945-2950 (2009).
111. Luijsterburg, M. S. et al. Heterochromatin protein 1 is recruited to various types of DNA damage. J. Cell Biol. 185, 577-586 (2009).
112. Zarebski, M., Wiernasz, E. & Dobrucki, J. W. Recruitment of heterochromatin protein 1 to DNA repair sites. Cytometry A 75, 619-625 (2009).
113. Baldeyron, C., Soria, G., Roche, D., Cook, A. J. & Almouzni, G. HP1α recruitment to DNA damage by p150CAF1 promotes homologous recombination repair. J. Cell Biol. 193, 81-95 (2011).
114. Sallmyr, A., Tomkinson, A. E. & Rassool, F. V. Upregulation of WRN and DNA ligase IIIα in chronic myeloid leukemia: Consequences for the repair of DNA double-strand breaks. Blood 112, 1413-1423 (2008).
115. Edwards, S. L. et al. Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451, 1111-1115 (2008).
116. Sakai, W. et al. Secondary mutations as a mechanism of cisplatin resistance in BRCA2mutated cancers. Nature 451, 1116-1120 (2008).
117. Chen, X. et al. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res. 68, 3169-3177 (2008).
118. Srivastava, M. et al. An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell 151, 1474-1487 (2012).
119. Davidson, D. et al. Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells. Invest. New Drugs 30, 1248-1256 (2012).
120. de Lange, T. et al. Structure and variability of human chromosome ends. Mol. Cell. Biol. 10, 518-527 (1990).
121. Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868 (1990).
122. d'Adda di Fagagna, F. et al. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11, 1192-1196 (2001).
123. Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645 (2000).
124. Artandi, S. E. & DePinho, R. A. Telomeres and telomerase in cancer. Carcinogenesis 31, 9-18 (2010).
125. Gisselsson, D. et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl Acad. Sci. USA 97, 5357-5362 (2000).
126. Celli, G. B. & de Lange, T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nature Cell Biol. 7, 712-718 (2005).
127. Celli, G. B., Denchi, E. L. & de Lange, T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nature Cell Biol. 8, 885-890 (2006).
128. Smogorzewska, A., Karlseder, J., Holtgreve-Grez, H., Jauch, A. & de Lange, T. DNA ligase IVdependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 12, 1635-1644 (2002).
129. Rai, R. et al. The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J. 29, 2598-2610 (2010).
130. Maser, R. S. et al. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol. Cell. Biol. 27, 2253-2265 (2007).
131. Callen, E. et al. 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell 20 May 3013 (doi: 10.1016/j.cell.2013.05.023).